Literature DB >> 15904649

Comparison of myocardial perfusion after successful primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction with versus without diabetes mellitus.

Jorik R Timmer1, Iwan C C van der Horst, Giuseppe de Luca, Jan Paul Ottervanger, Jan C A Hoorntje, Menko-Jan de Boer, Harry Suryapranata, Jan-Henk E Dambrink, Marcel Gosselink, Felix Zijlstra, Arnoud W J van 't Hof.   

Abstract

Patients with diabetes mellitus (DM) have an adverse prognosis after ST-segment elevation myocardial infarction (STEMI). Whether DM was associated with impaired myocardial reperfusion after successful primary percutaneous coronary intervention for STEMI was investigated. Myocardial reperfusion was assessed by ST-segment resolution and myocardial blush grade (MBG). A total of 386 patients were studied, of whom 64 (17%) had DM. These patients more frequently had reduced MBG (20% vs 10%, p = 0.02) and incomplete ST-segment resolution (55% vs 35%, p = 0.02) compared with patients without DM. After multivariate analysis, DM was still associated with impaired ST resolution (odds ratio 2.1, p = 0.03) and reduced MBG (odds ratio 2.2, p = 0.03).

Entities:  

Mesh：

Year:  2005        PMID： 15904649     DOI： 10.1016/j.amjcard.2005.01.088

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  8 in total

1.  Gender-related differences in outcome after ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation.

Authors:  Giuseppe De Luca; C Michael Gibson; Mariann Gyöngyösi; Uwe Zeymer; Dariusz Dudek; Hans-Richard Arntz; Francesco Bellandi; Mauro Maioli; Marko Noc; Simona Zorman; H Mesquita Gabriel; Ayse Emre; Donald Cutlip; Tomasz Rakowski; Kurt Huber; Arnoud W J van't Hof
Journal:  J Thromb Thrombolysis       Date:  2010-10       Impact factor: 2.300

Review 2.  ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on 'coronary microvascular dysfunction in cardiovascular disease'.

Authors:  Teresa Padro; Olivia Manfrini; Raffaele Bugiardini; John Canty; Edina Cenko; Giuseppe De Luca; Dirk J Duncker; Etto C Eringa; Akos Koller; Dimitris Tousoulis; Danijela Trifunovic; Marija Vavlukis; Cor de Wit; Lina Badimon
Journal:  Cardiovasc Res       Date:  2020-03-01       Impact factor: 10.787

3.  Impact of diabetes on immature platelets fraction and its relationship with platelet reactivity in patients receiving dual antiplatelet therapy.

Authors:  Monica Verdoia; Patrizia Pergolini; Matteo Nardin; Roberta Rolla; Lucia Barbieri; Alon Schaffer; Paolo Marino; Giorgio Bellomo; Harry Suryapranata; Giuseppe De Luca
Journal:  J Thromb Thrombolysis       Date:  2016-08       Impact factor: 2.300

4.  Impact of diabetes on long-term outcome in STEMI patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors and BMS or DES.

Authors:  Giuseppe De Luca; Rosario Sauro; Attilio Varricchio; Michele Capasso; Tonino Lanzillo; Fiore Manganelli; Ciro Mariello; Francesco Siano; Giannignazio Carbone; Maria Rosaria Pagliuca; Giuseppe Rosato; Emilio Di Lorenzo
Journal:  J Thromb Thrombolysis       Date:  2010-08       Impact factor: 2.300

5.  Benefits of pharmacological facilitation with glycoprotein IIb-IIIa inhibitors in diabetic patients undergoing primary angioplasty for STEMI. A subanalysis of the EGYPT cooperation.

Authors:  Giuseppe De Luca; C Michael Gibson; Francesco Bellandi; Sabina Murphy; Mauro Maioli; Marko Noc; Uwe Zeymer; Dariusz Dudek; Hans-Richard Arntz; Simona Zorman; H Mesquita Gabriel; Ayse Emre; Donald Cutlip; Tomasz Rakowski; Mariann Gyongyosi; Kurt Huber; Arnoud W J Van't Hof
Journal:  J Thromb Thrombolysis       Date:  2008-11-22       Impact factor: 2.300

6.  Impact of diabetes on long-term outcome after primary angioplasty: insights from the DESERT cooperation.

Authors:  Giuseppe De Luca; Maurits T Dirksen; Christian Spaulding; Henning Kelbæk; Martin Schalij; Leif Thuesen; Bas van der Hoeven; Marteen A Vink; Christoph Kaiser; Carmine Musto; Tania Chechi; Gaia Spaziani; Luis Salvador Diaz de la Llera; Vincenzo Pasceri; Emilio Di Lorenzo; Roberto Violini; Harry Suryapranata; Gregg W Stone
Journal:  Diabetes Care       Date:  2012-12-28       Impact factor: 19.112

7.  Diabetes mellitus and glucose as predictors of mortality in primary coronary percutaneous intervention.

Authors:  Renato Budzyn David; Eduardo Dytz Almeida; Larissa Vargas Cruz; Juliana Cañedo Sebben; Ivan Petry Feijó; Karine Elisa Schwarzer Schmidt; Luísa Martins Avena; Carlos Antonio Mascia Gottschall; Alexandre Schaan de Quadros
Journal:  Arq Bras Cardiol       Date:  2014-09-12       Impact factor: 2.000

Review 8.  Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotection.

Authors:  Jake Russell; Eugene F Du Toit; Jason N Peart; Hemal H Patel; John P Headrick
Journal:  Cardiovasc Diabetol       Date:  2017-12-04       Impact factor: 9.951
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.